Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RNA
Biotech
Bayer-allied NextRNA Therapeutics winds down operations
The closure comes a year after NextRNA inked a two-program oncology pact with Bayer worth up to $547 million in upfront and milestone payments.
Darren Incorvaia
Aug 11, 2025 2:30pm
Flagship's Sail sends staff packing for 2nd time this year
Jul 18, 2025 12:55pm
AIRNA preps for clinical test with $155M series B
Apr 1, 2025 7:00am
Eli Lilly jumps deeper into AI with $409M Genetic Leap deal
Sep 5, 2024 9:16am
Pfizer signs $331M deal with Ginkgo for unspecified targets
Sep 27, 2023 9:50am
New RNA biotech raises $300M in largest private round of 2023
May 23, 2023 6:30am
